Not all that glitters is COVID! Differential diagnosis of FDG-avid interstitial lung disease in low-prevalence regions.
Annalisa PapaChiara PozzessereFrancesco CiconeFabiola RizzutoGiuseppe Lucio CasciniPublished in: European journal of hybrid imaging (2020)
Coronavirus disease-19 (COVID-19) is only one of the many possible infectious and non-infectious diseases that may occur with similar imaging features in patients undergoing [18F]-fluorodeoxyglucose (18FDG) monitoring, particularly in the most fragile oncologic patients. We briefly summarise some key radiological elements of differential diagnosis of interstitial lung diseases which, in our opinion, could be extremely useful for physicians reporting 18FDG PET/CT scans, not only during the COVID-19 pandemic, but also for their normal routine activity.
Keyphrases
- coronavirus disease
- positron emission tomography
- interstitial lung disease
- pet ct
- infectious diseases
- computed tomography
- patients undergoing
- systemic sclerosis
- sars cov
- end stage renal disease
- respiratory syndrome coronavirus
- pet imaging
- newly diagnosed
- primary care
- chronic kidney disease
- ejection fraction
- high resolution
- idiopathic pulmonary fibrosis
- prognostic factors
- risk factors
- prostate cancer
- peritoneal dialysis
- emergency department
- magnetic resonance imaging
- clinical practice
- rectal cancer
- adverse drug
- contrast enhanced
- patient reported